Identification and Characterization of a Pro-tumor Necrosis Factor-α-processing Enzyme from the ADAM Family of Zinc Metalloproteases*

Tumor necrosis factor-α (TNF) is initially expressed as a 26-kDa membrane-bound precusor protein (pro-TNF) that is shed proteolytically from the cell surface, releasing soluble 17-kDa TNF. We have identified human ADAM 10 (HuAD10) from THP-1 membrane extracts as a metalloprotease that specifically clips a peptide substrate spanning the authentic cleavage site between Ala76 and Val77 in pro-TNF. To confirm that HuAD10 has TNF processing activity, we cloned, expressed, and purified an active, truncated form of HuAD10. Characterization of recombinant HuAD10 (rHuAD10) suggests that this enzyme has many of the properties (i.e. substrate specificity, metalloprotease activity, cellular location) expected for a physiologically relevant TNF-processing enzyme.

[1]  M. Lambert,et al.  Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α , 1997, Nature.

[2]  Nicole Nelson,et al.  A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.

[3]  S. Narula,et al.  Purification of ADAM 10 from bovine spleen as a TNFα convertase , 1997 .

[4]  M. Paine,et al.  Processing of pro‐tumor necrosis factor‐α by venom metalloproteinases: A hypothesis explaining local tissue damage following snake bite , 1996, European journal of immunology.

[5]  P. Glynn,et al.  Molecular cloning of MADM: a catalytically active mammalian disintegrin-metalloprotease expressed in various cell types. , 1996, The Biochemical journal.

[6]  J. Massagué,et al.  Diverse Cell Surface Protein Ectodomains Are Shed by a System Sensitive to Metalloprotease Inhibitors (*) , 1996, The Journal of Biological Chemistry.

[7]  R. Black,et al.  A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. , 1995, Journal of immunology.

[8]  S. Roman-Roman,et al.  In Vitro Processing of Human Tumor Necrosis Factor-α (*) , 1995, The Journal of Biological Chemistry.

[9]  T G Wolfsberg,et al.  ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell- matrix interactions , 1995, The Journal of cell biology.

[10]  D. Hommes,et al.  Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). , 1995, Gastroenterology.

[11]  R. Black,et al.  A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes , 1995, The Journal of experimental medicine.

[12]  J. Woody,et al.  Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis , 1994, The Lancet.

[13]  M. Gerhart,et al.  Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing , 1994, Nature.

[14]  N. Hooper,et al.  Characterization of a secretase activity which releases angiotensin-converting enzyme from the membrane. , 1993, The Biochemical journal.

[15]  E. Huang,et al.  Cleavage of membrane-anchored growth factors involves distinct protease activities regulated through common mechanisms. , 1992, The Journal of biological chemistry.

[16]  T. Watanabe,et al.  Sequence requirements for precursor cleavage within the constitutive secretory pathway. , 1992, The Journal of biological chemistry.

[17]  J. Woessner,et al.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  S. Yamamoto,et al.  Molecular cloning of cDNA encoding MS2 antigen, a novel cell surface antigen strongly expressed in murine monocytic lineage. , 1990, International immunology.

[19]  Bharat B. Aggarwal,et al.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin , 1984, Nature.

[20]  K. Balakrishnan,et al.  A simple and rapid method for the preparation of plasma membranes. , 1983, Biochimica et biophysica acta.

[21]  R. B. Merrifield.  Solid phase peptide synthesis. I. the synthesis of a tetrapeptide , 1963 .

[22]  H. Wanebo,et al.  Tumor necrosis factors. , 1989, Seminars in surgical oncology.